Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Vertex’s VX-548 For Acute Pain May Be Right On Time For Market
Medicare Policy Change In 2025 Favors Non-Opioids
Jan 31 2024
•
By
Mandy Jackson
VX-548 succeeded in Phase III abdominoplasty and bunionectomy studies • Source: Shutterstock
More from Clinical Trials
More from R&D